Kristian A. Werling - McDermott Will & Emery

Overview


Kristian (Krist) Werling represents private equity and strategic investors in a wide variety of transactional matters in the healthcare and life sciences industry. In this capacity, he works with cross-disciplinary teams to conduct legal due diligence and execute acquisitions and divestitures, as well as provide ongoing legal services to portfolio companies. Krist is a co-head of the Firm’s Private Equity Practice Group.

Show More

Results


  • Ampersand Capital Partners in a wide variety of transactions including the acquisition of New England Peptides, Peptides International, Tjoapack, Canopy Biosciences, Zellwerkraft, Adaptas/ETP Ion Detect, Cadence Fluidics, Pharma Packaging Solutions, Applied Kilovolts, Genome Diagnostics and Sanova Dermatology as well as the sale of Adaptas Solutions to IMI Plc
  • Amulet Capital Partners in a wide variety of transactions including the formation of and investment in US Fertility through the acquisition of Integramed and Shady Grove Fertility as well as the formation and investment in Children’s Choice Dental Management, Children’s Choice Dental Management, Dental Brands, Children’s Dental Support Services, LLC and Desert Valley Pediatric Dentistry as well as the formation of US Fertility
  • Baxter International in a wide variety of transactions including the acquisition of a portfolio of hemostasis product lines from Mallinckrodt, multiple undisclosed acquisitions of liquid injectable pharmaceutical products, the acquisition of Chatham Therapeutics, strategic licenses with ScinoPharm Taiwan and Merrimack Pharmaceuticals and acquiring the rights to manufacture and sell Scopoderm from GlaxoSmithKline

Show More

Recognitions


  • Crain’s Chicago Business, Notable Gen X Leader in Law, 2021
  • Chambers USA 2022
  • The Legal 500 US 2017, 2019 and 2022

Show More

Community


  • North Park University Board of Trustees
  • American Health Lawyers Association, former chair of the Life Science Practice Group, and editor in chief of the second edition of The Fundamentals of Life Sciences Law: Drugs, Devices, and Biotech

Credentials


Education
Northwestern University J.L. Kellogg School of Management, MBA, 2010
University of Illinois College of Law, JD, magna cum laude, 2002
North Park University Chicago, BA, cum laude, 1999

Admissions
Illinois